Health
Weighing risks and benefits of COVID-19 vaccination in children – Medical Xpress
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical…
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical trial results indicate the vaccine is safe and effective in this age group.
This is an important development. COVID-19 infectionsare…
Continue Reading
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General22 hours agoSharp rise in airfares push UK inflation higher in July
-
Business17 hours agoAre BHP shares are buy after its results?